Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03693456 · ClinicalTrials.gov registry record · NA
Food Allergy Diagnostic Test Response to Previous Oral Challenge Response
A NA study, sponsored by ORA.
- Completed
- Registry status
- NA
- Development phase
- 19
- Enrollment target
NCT03693456: Completed NA study, sponsored by ORA.
NCT03693456 is a NA study that has completed, run by ORA. The registered enrollment target is 19 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03693456, a NA study, has completed, sponsored by ORA.
- COMPLETED
- Registry status
- NA
- Development phase
- 19 participants
- Enrollment target
Study Summary
The objective of this study is to compare the ocular response to CAC (using food allergen sensitive patients) to the systemic response of a previously performed oral food allergen challenge in the same subjects. This study will investigate the potential utility of CAC as a predictive tool for identifying patient response to food allergen challenge and maximum tolerated dose.
Interventions
- OTHER Conjunctival Allergen Challenge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2016-05 |
| Est. Completion | 2016-10 |
| Phase | NA |
What the finished NCT03693456 record still lists
NCT03693456 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 19 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Conjunctival Allergen Challenge is the first listed.
NCT03693456 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03693456 about?
NCT03693456 is a clinical study titled "Food Allergy Diagnostic Test Response to Previous Oral Challenge Response". The objective of this study is to compare the ocular response to CAC (using food allergen sensitive patients) to the systemic response of a previously performed oral food allergen challenge in the same subjects. This study will investigate the potential utility of CAC as a predictive tool for identi...
What is the current status of trial NCT03693456?
This trial is currently completed. It is a NA study. The enrollment target is 19 participants. The study started on 2016-05. Estimated completion is 2016-10.
What interventions are being tested in trial NCT03693456?
The interventions under investigation include: Conjunctival Allergen Challenge (OTHER).
Who is sponsoring clinical trial NCT03693456?
This trial is sponsored by ORA, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03693456's enrollment target sits among peer trials
19 1861st of 2000 higher than 138 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia